Better Therapeutics Inc (BTTX)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 17, 15:41
Better Therapeutics Shareholders Equity (Quarterly): -9.937M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -9.937M |
| June 30, 2023 | -10.79M |
| March 31, 2023 | -9.833M |
| December 31, 2022 | -0.899M |
| September 30, 2022 | 7.252M |
| Date | Value |
|---|---|
| June 30, 2022 | 18.05M |
| March 31, 2022 | 27.42M |
| December 31, 2021 | 36.72M |
| September 30, 2021 | 55.54M |
| June 30, 2021 | -20.68M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.68M
Minimum
Jun 2021
55.54M
Maximum
Sep 2021
9.286M
Average
3.176M
Median
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 344.87M |
| SELLAS Life Sciences Group Inc | 9.684M |
| Biotricity Inc | -26.73M |
| Immuneering Corp | 78.72M |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.72M |
| Total Liabilities (Quarterly) | 20.66M |